🇺🇸 ILMN — Illumina, Inc.

Salud Mantener
← Volver

Precio actual

226,54 USD

Máx. histórico

510,54

1906 días

Split 1028:1000 del 25/06/2024

Caída desde máximo

-55,63%

Rango 52 semanas

112,65 – 309,35

Variación hoy

-4,90%

Cierre anterior

238,21

Rango de hoy

224,05 – 244,05

Volumen hoy

3.035.725

Peor caída histórica

-96,14%

01/09/2000 → 13/03/2003

Recuperado en 1595 días

Volatilidad anualizada ⓘ

56,40%

Información
Nombre completo
Illumina, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Diagnostics & Research
Empleados
8.600
PER ⓘ
37,08 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
261,60 USD (puede no estar actualizado)
Primera cotización
28/07/2000
Precio actualizado
hace 5 horas
Sobre la empresa

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2024 1028:1000
23/09/2008 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/03/2017 161,09 162,17 159,78 161,07 -0,67% 1,49% 715.180
06/03/2017 163,29 163,41 161,99 162,15 -1,07% 0,87% 697.190
03/03/2017 163,18 164,06 161,85 163,91 +0,47% 1,35% 887.370
02/03/2017 164,05 166,55 161,93 163,15 -0,64% 2,82% 827.232
01/03/2017 163,99 165,35 162,98 164,20 +0,84% 1,45% 1.047.429
28/02/2017 161,84 164,02 161,10 162,84 +0,35% 1,80% 1.576.438
27/02/2017 159,26 162,92 156,88 162,28 +4,26% 3,79% 1.593.503
24/02/2017 156,46 156,57 154,48 155,64 -0,63% 1,33% 774.084
23/02/2017 158,56 158,56 155,97 156,62 -0,79% 1,63% 578.044
22/02/2017 157,39 158,95 156,63 157,88 +0,09% 1,47% 657.612
21/02/2017 158,67 159,05 156,17 157,73 -0,75% 1,81% 730.291
17/02/2017 156,91 159,01 156,73 158,92 +1,28% 1,45% 917.387
16/02/2017 159,00 159,39 155,03 156,91 -1,22% 2,74% 1.054.934
15/02/2017 159,38 160,87 158,56 158,84 -0,71% 1,45% 807.597
14/02/2017 159,74 161,18 158,71 159,98 +0,38% 1,55% 787.140
13/02/2017 158,66 160,17 157,65 159,38 +0,49% 1,59% 806.055
10/02/2017 159,20 159,20 156,86 158,60 -0,06% 1,47% 928.284
09/02/2017 158,42 159,47 157,99 158,70 +0,11% 0,94% 478.842
08/02/2017 158,07 159,14 157,00 158,52 +0,07% 1,35% 615.361
07/02/2017 157,94 159,53 157,39 158,41 +0,20% 1,36% 717.955
06/02/2017 156,87 158,56 156,76 158,09 +0,23% 1,15% 723.918
03/02/2017 158,06 159,79 156,34 157,73 -0,45% 2,18% 831.035
02/02/2017 156,04 158,68 155,16 158,45 +0,81% 2,26% 962.928
01/02/2017 153,70 159,34 152,24 157,18 +0,92% 4,62% 1.840.428
31/01/2017 154,94 156,23 153,40 155,74 +0,51% 1,82% 1.792.215
30/01/2017 156,52 156,53 152,58 154,94 -1,06% 2,52% 1.102.016
27/01/2017 156,56 157,19 155,56 156,61 +0,54% 1,04% 984.721
26/01/2017 156,91 157,43 155,54 155,77 -0,58% 1,21% 717.338
25/01/2017 156,57 157,48 155,65 156,68 +0,37% 1,17% 920.266
24/01/2017 156,51 156,93 154,00 156,11 -0,25% 1,87% 868.866